Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus
Federico Fabris, Stefano Varani, Marika Tonellato, Ivica Matak, Petra Šoštarić, Patrik Meglić, Matteo Caleo, Aram Megighian, Ornella Rossetto, Cesare Montecucco, Marco Pirazzini
Federico Fabris, Stefano Varani, Marika Tonellato, Ivica Matak, Petra Šoštarić, Patrik Meglić, Matteo Caleo, Aram Megighian, Ornella Rossetto, Cesare Montecucco, Marco Pirazzini
View: Text | PDF
Research Article Neuroscience

Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus

  • Text
  • PDF
Abstract

Cephalic tetanus (CT) is a severe form of tetanus that follows head wounds and the intoxication of cranial nerves by tetanus neurotoxin (TeNT). Hallmarks of CT are cerebral palsy, which anticipates the spastic paralysis of tetanus, and rapid evolution of cardiorespiratory deficit even without generalized tetanus. How TeNT causes this unexpected flaccid paralysis, and how the canonical spasticity then rapidly evolves into cardiorespiratory defects, remain unresolved aspects of CT pathophysiology. Using electrophysiology and immunohistochemistry, we demonstrate that TeNT cleaves its substrate vesicle-associated membrane protein within facial neuromuscular junctions and causes a botulism-like paralysis overshadowing tetanus spasticity. Meanwhile, TeNT spreads among brainstem neuronal nuclei and, as shown by an assay measuring the ventilation ability of CT mice, harms essential functions like respiration. A partial axotomy of the facial nerve revealed a potentially new ability of TeNT to undergo intra-brainstem diffusion, which allows the toxin to spread to brainstem nuclei devoid of direct peripheral efferents. This mechanism is likely to be involved in the transition from local to generalized tetanus. Overall, the present findings suggest that patients with idiopathic facial nerve palsy should be immediately considered for CT and treated with antisera to block the potential progression to a life-threatening form of tetanus.

Authors

Federico Fabris, Stefano Varani, Marika Tonellato, Ivica Matak, Petra Šoštarić, Patrik Meglić, Matteo Caleo, Aram Megighian, Ornella Rossetto, Cesare Montecucco, Marco Pirazzini

×

Figure 4

TeNT activity in the brainstem after injection in the WP is found at the level of inhibitory axon terminals.

Options: View larger image (or click on image) Download as PowerPoint
TeNT activity in the brainstem after injection in the WP is found at the...
(A) Cartoon showing TeNT injection (1 ng/kg in a final volume of 1 μL) in the WP. (B) TeNT activity causes the appearance and progressive accumulation of cl-VAMP (red) in the facial nucleus (FN), which acts as a reporter to illuminate the brainstem areas reached by the toxin. As soon as 1 day after injection, the ipsilateral FN displays a strong signal of cl-VAMP (upper panels), which increases over time, though the mice still have flaccid paralysis (bottom panels). From day 3, a faint signal appears also in the contralateral side, when the noninjected WP starts to be spastic, and becomes clearly stained at day 5, when the spasticity of the noninjected WP is fully attained; scale bars, 500 μm. (C) The signal of cl-VAMP (red) is surrounded by the staining of GlyT2 (green), the plasma membrane transporter involved in the reuptake of glycine in the synaptic cleft, indicating that TeNT mainly acts within the presynaptic cytoplasm of inhibitory interneurons; scale bar, 25 μm. The insets show a 10× original magnification. (D) The signal of cl-VAMP (red) appears as puncta and colocalizes with the vesicular transporter of GABA and glycine (VGAT, green), indicating that TeNT activity occurs specifically at the level of synaptic vesicles within inhibitory axon terminals; scale bar, 10 μm. The insets show a 3× original magnification. (E) Pearson’s colocalization analysis between cl-VAMP (red) and VGAT (green) signals shown as a scatterplot (top panel) and as a histogram of the correlation coefficient (bottom panel). Black circles indicate the number of brainstem slices used for the analysis.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts